The global animal model market is estimated to garner a revenue of around US$ 1,943.3 million in 2024. Animals possess a shorter life cycle, a high genotype resemblance, and are easy to test in laboratories.
As per the animal model demand analysis report, the overall market is predicted to grow at a moderate CAGR of 6% over the next ten years. The report also forecasts the global animal model industry to reach a value of nearly US$ 3,476.8 million by the end of this forecast period.
Animal Model Market Trends and Analysis
| Report Attribute | Details |
|---|---|
| Animal Model Market Revenue (2024) | US$ 1,943.3 million |
| Market Anticipated Forecast Value (2034) | US$ 3,476.8 million |
| Market Projected Growth Rate (2024 to 2034) | 6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2019, the net revenue generated by animal model suppliers and service providers was assessed to be around US$ 1,425 million. The global animal model market witnessed a growth rate of 6.4% from 2019 to 2023.
During this period, the animal model market had been facing tremendous pressure from animal welfare organizations and activists in various countries. However, the situation has changed drastically since the outbreak of COVID-19. This change in situation was due to animal model testing being central in research towards developing an effective vaccine against novel coronavirus or other pathogens.
| Historical Market CAGR (2019 to 2023) | 6.4% |
|---|---|
| Forecasted Market CAGR (2024 to 2034) | 6% |
The industry also received a significant fillip during this period due to a rapid rise in demand for non-human primates for research into COVID-19 vaccines. This research is expected to continue in the near future, driving the demand for different species for preclinical models.
Alternatives such as cell cultures, tissue cultures, and computer models are also available. However, animal models are preferred owing to the complexity of the living systems. Significant incidence rates of diseases, along with adverse effects of drugs, have driven the adoption of animal models to ensure the safety of humans. So, the persisting demand for laboratory animals in pharmacological studies is expected to strengthen the market with the expansion of the pharmaceutical sector.
Pharmacological studies, which include target identification & validation, toxicology drug screening & lead optimization & safety screening, have also surged the demand for advanced animal models for preclinical research. For instance, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical businesses spent roughly US$ 79.6 billion on research and development in the United States in 2018.
Government intervention in academic and research institutions is increasing for the development of standard protocols related to animal models. Researchers utilize animal models for basic research, such as developing new therapeutic strategies to treat human diseases and preclinical analyses of developed drug safety & efficacy. Moreover, continued advances in animal models, the availability of modern healthcare systems, and a considerable increase in demand for modern healthcare facilities are also expected to propel the market to some degree.
One of the major restraints in the adoption of some animal models is the risk of researchers using animal models being susceptible to false analogy, where implications built around assumptions of similarities between animals and humans can potentially lead to an incorrect conclusion.
Principal Consultant
The table below puts together the CAGRs for a few countries expected to witness a notable increment in their share of the animal model industry. In North American and European countries witness robust growth rates with relevant policies being reformed by the government to spur funding plans related to animal model research. Several animal model solution providers in Asia are also expected to make huge investments in biogenic research which is reflected in the promising growth rates of China and Japan.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 6.7% |
| Germany | 8.2% |
| United Kingdom | 6.6% |
| Japan | 4.7% |
| China | 6.1% |
The demand for experimental animals in the United States for in vivo models is predicted to increase 6.7% through the projected years. The United States is likely to be a dominating country in the animal model market because of
The market in China holds a significant share of the global market and is likely to maintain its dominance in Asia for laboratory animals for pharmacological studies. Some prominent factors that are expected to drive the China market at 6.1% CAGR through the forecast period include:
Based on species, revenue from rat-based animal models is estimated to account for a 37.3% market share in 2024.
| Attributes | Details |
|---|---|
| Top Species Type or Segment | Rats |
| Market Share in 2024 | 37.3% |
Revenue from the use of rats in animal models is also slated to expand through the forecasted years due to the following reasons:
The development of animal models for drug discovery is expected to account for nearly 54.4% of the market share in 2024.
| Attributes | Details |
|---|---|
| Top Application Type | Drug Discovery and Development |
| Market Share in 2024 | 54.4% |
A few key factors that are expected to retain the dominance of the drug discovery and development segment through the forecast years include:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by leading companies have created prospects for the market to expand globally.
The market is now highly influenced by technological interventions in software modeling for time and cost efficiency, along with the growing ethical concerns in reducing the number of live animals used for research. Recent key developments in the market include the development of a novel monkey research model using CRISPR technology.
Recent Developments in the Global Animal Model Market
In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth's unique CRISPR technology. The partnership is expected to make it easier for Horizon to provide a new generation of genetically altered CHO cells to manufacture biotherapeutics such as therapeutic antibodies.
In March 2022, Charles River Laboratories and Hera Biolabs inked a contract for the breeding, marketing, and sales of SRG rats to the world's preclinical research community. Through this deliberate partnership, Hera BioLabs is aiming to expand the geographic reach of its highly immunodeficient rat model.
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 1,943.3 million |
| Projected Market Size (2034) | US$ 3,476.8 million |
| Anticipated Growth Rate (2024 to 2034) | 6% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Species Type, By Application, By End User, and By Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global animal model market is estimated to be valued at US$ 1,943.3 million in 2024.
The global animal model market is to grow at 6% during the forecast period.
The global animal model market is predicted to be valued at US$ 3,476.8 million by 2034.
The United States accounts for over one-fourth revenue share of the global market.
Germany is predicted to witness an 8.2% CAGR in the adoption of animal models through 2034.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Species
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Species, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Species, 2024 to 2034
5.3.1. Rats
5.3.2. Mice
5.3.3. Guinea Pigs
5.3.4. Rabbits
5.3.5. Monkeys
5.3.6. Dogs
5.3.7. Pigs
5.3.8. Cats
5.3.9. Other Species
5.4. Y-o-Y Growth Trend Analysis By Species, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Species, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034
6.3.1. Academic & Research Institutions
6.3.2. Pharmaceutical Companies
6.3.3. Biotechnology Companies
6.3.4. Contract Research Organizations (CROs)
6.3.5. Other End Users
6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034
7.3.1. Basic and Applied Research
7.3.2. Drug Discovery/Development
7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Species
9.2.3. By End User
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Species
9.3.3. By End User
9.3.4. By Application
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Species
10.2.3. By End User
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Species
10.3.3. By End User
10.3.4. By Application
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Species
11.2.3. By End User
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Species
11.3.3. By End User
11.3.4. By Application
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Species
12.2.3. By End User
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Species
12.3.3. By End User
12.3.4. By Application
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Species
13.2.3. By End User
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Species
13.3.3. By End User
13.3.4. By Application
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Species
14.2.3. By End User
14.2.4. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Species
14.3.3. By End User
14.3.4. By Application
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Species
15.2.3. By End User
15.2.4. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Species
15.3.3. By End User
15.3.4. By Application
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Species
16.1.2.2. By End User
16.1.2.3. By Application
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Species
16.2.2.2. By End User
16.2.2.3. By Application
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Species
16.3.2.2. By End User
16.3.2.3. By Application
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Species
16.4.2.2. By End User
16.4.2.3. By Application
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Species
16.5.2.2. By End User
16.5.2.3. By Application
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Species
16.6.2.2. By End User
16.6.2.3. By Application
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Species
16.7.2.2. By End User
16.7.2.3. By Application
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Species
16.8.2.2. By End User
16.8.2.3. By Application
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Species
16.9.2.2. By End User
16.9.2.3. By Application
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Species
16.10.2.2. By End User
16.10.2.3. By Application
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Species
16.11.2.2. By End User
16.11.2.3. By Application
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Species
16.12.2.2. By End User
16.12.2.3. By Application
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Species
16.13.2.2. By End User
16.13.2.3. By Application
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Species
16.14.2.2. By End User
16.14.2.3. By Application
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Species
16.15.2.2. By End User
16.15.2.3. By Application
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Species
16.16.2.2. By End User
16.16.2.3. By Application
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Species
16.17.2.2. By End User
16.17.2.3. By Application
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Species
16.18.2.2. By End User
16.18.2.3. By Application
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Species
16.19.2.2. By End User
16.19.2.3. By Application
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Species
16.20.2.2. By End User
16.20.2.3. By Application
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Species
16.21.2.2. By End User
16.21.2.3. By Application
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Species
16.22.2.2. By End User
16.22.2.3. By Application
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Species
16.23.2.2. By End User
16.23.2.3. By Application
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Species
17.3.3. By End User
17.3.4. By Application
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Charles River Laboratories International, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Horizon Discovery Group plc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. The Jackson Laboratory
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Taconic Biosciences, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Genoway SA
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Eurofins Scientific SE
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Crown Bioscience, Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Envigo CRS SA
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Transposagen Biopharmaceuticals, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Animal Model Market
